Literature DB >> 22994730

Sun exposure and the risk of prostate cancer in the Singapore Prostate Cancer Study: a case-control study.

Sin-Eng Chia1, Kin-Yoke Wong, Christopher Cheng, Weber Lau, Puay-Hoon Tan.   

Abstract

BACKGROUND: Most of the epidemiology studies on the effects of sun exposure and prostate cancer were conducted among the temperate countries of North America and Europe. Little is known about the influence on Asian populations. The purpose of current study was to evaluate any association of sun exposure with risk of prostate cancer in Chinese, Malays and Indians who reside in the tropics.
METHODS: The Singapore Prostate Cancer Study is a hospital-based case-control study of 240 prostate cancer incident cases and 268 controls conducted in Singapore between April 2007 and May 2009. Detailed information on outdoor activities in the sun, skin colour, sun sensitivity and other possible risk factors were collected in personal interviews. Cases were further classified by Gleason scores and TNM staging. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression analysis, adjusted for age, ethnicity, education, family history of any cancers, BMI and skin colour.
RESULTS: We found that prostate cancer risk was increased in subjects with black/dark-brown eyes (OR 5.88, 95%CI 3.17-10.9), darker skin colour e.g. tan/dark brown/black (OR 7.62, 95%CI 3.41-17.0), frequent sunburn in lifetime (OR 4.30, 95%CI 1.7-11.2) and increased general sun exposure in adulthood per week (OR 2.03, 95%CI 1.09-3.81). The increased risk was consistent for high grade tumours and advanced stage prostate cancers.
CONCLUSION: The findings from this study suggest that excessive sun exposure is a risk factor for prostate cancer in Asians.

Entities:  

Mesh:

Year:  2012        PMID: 22994730     DOI: 10.7314/apjcp.2012.13.7.3179

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry.

Authors:  D Cole-Clark; V Nair-Shalliker; A Bang; K Rasiah; V Chalasani; D P Smith
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

2.  Association between environmental quality and prostate cancer stage at diagnosis.

Authors:  Hari T Vigneswaran; Jyotsna S Jagai; David T Greenwald; Achal P Patel; Megh Kumar; Ryan W Dobbs; Daniel M Moreira; Michael R Abern
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-05-04       Impact factor: 5.554

3.  Sunlight exposure during leisure activities and risk of prostate cancer in Montréal, Canada, 2005-2009.

Authors:  Jennifer Yu; Jérôme Lavoué; Marie-Élise Parent
Journal:  BMC Public Health       Date:  2014-07-28       Impact factor: 3.295

4.  Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels.

Authors:  Visalini Nair-Shalliker; Sam Egger; Agata Chrzanowska; Rebecca Mason; Louise Waite; David Le Couteur; Markus J Seibel; David J Handelsman; Robert Cumming; David P Smith; Bruce K Armstrong
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

5.  PAX3 is a biomarker and prognostic factor in melanoma: Database mining.

Authors:  Yong Liu; Shengnan Cui; Wenbin Li; Yiding Zhao; Xiaoning Yan; Jianqin Xu
Journal:  Oncol Lett       Date:  2019-03-18       Impact factor: 2.967

6.  Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.

Authors:  Sean Harrison; Kate Tilling; Emma L Turner; Richard M Martin; Rosie Lennon; J Athene Lane; Jenny L Donovan; Freddie C Hamdy; David E Neal; J L H Ruud Bosch; Hayley E Jones
Journal:  Cancer Causes Control       Date:  2020-03-11       Impact factor: 2.506

7.  Prostate cancer risk in patients with melanoma: A systematic review and meta-analysis.

Authors:  Prakash Acharya; Mahesh Mathur
Journal:  Cancer Med       Date:  2020-03-16       Impact factor: 4.452

Review 8.  Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.

Authors:  Yuxin Lin; Xiaojun Zhao; Zhijun Miao; Zhixin Ling; Xuedong Wei; Jinxian Pu; Jianquan Hou; Bairong Shen
Journal:  J Transl Med       Date:  2020-03-07       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.